News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Thrombotargets Corporation Announces the Membership of its Scientific Advisory Board



7/25/2007 12:33:28 PM

Durham, North Carolina, June 1, 2007- Thrombotargets Corp., a privately owned biotech company focused on the development of new drug candidates and technologies on the field of hemostasia, today announced the membership of its new Scientific Advisory Board. The Scientific Advisory Board members have been selected for their expertise on hemostasia, especially by their knowledge of vascular biology, coagulation diseases management, and dental procedure treatment of coagulation disease patients.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES